Interestingly, Taniue et al. recently demonstrated that transactivation of TCF3 by β-catenin is required for β-catenin-mediated proliferation of CRC cells, and ATF3 was specifically inhibited by TCF3 in CRC13, which is consistent with the data in the current study. This evidence concerns the gene ATF3 and colorectal carcinoma.